The Molecular Quality Controls Market size was estimated USD 0.17 billion in 2022 and is expected to reach USD 0.28 billion by 2030 at a CAGR of 6.8% during the forecast period of 2023-2030.
The need for crucial and precise diagnostic information is growing as more hereditary and transmissible diseases come to light. Any deviation in diagnostic goods that can have an impact on decisions about laboratory product quality is tested for and reported through molecular quality control. The rise in third-party quality controls, the expansion of accredited clinical laboratories, and the expansion of government financing for genomic research are the main factors fueling the expansion of this market. Increasing demand for multi-analyte controls and growth prospects in emerging nations are anticipated to present chances for market participants throughout the anticipated timeframe.
.png)
A major factor in the development of customized medicine has been genomics. For best results, personalized medicine offers treatments and preventative measures that are specifically designed for each patient's situation. The most promising method to treat illnesses that aren't known to respond well to current therapies or cures is provided by this discipline of medicine. based on the PMC (Personalized Medicine Coalition) paper on personalized medicine.
DRIVERS
Increasing preference for personalized medicines
Adoption of Third-Party Quality Controls
the provision of funding to researchers for the creation of innovative interventions
Numerous governmental and corporate organizations are increasing the amount of money they spend on creating cutting-edge interventions and therapies that benefit the market. The market for molecular quality controls is also positively impacted by the rise in demand for efficient treatments, surge in healthcare spending, prevalence of HIV infection, population growth, changes in lifestyle, and rise in need for external quality evaluation.
RESTRAIN
Financial limitations in clinical laboratories
Dental radiologists are particularly in short supply in poor areas, which will impede industry expansion.
OPPORTUNITY
Rising demand for multi- analyst control
As a result of technological advancements, a new range of multi-analyte and multi-instrument controllers has been produced. With the help of these innovative controls, clinical laboratories can spend less money by combining many instrument-specific controls into one control. Additionally, by using these controls, time-consuming separate QC processes for each individual analyte are avoided. Seraseq Controls (SeraCare), Introl Series (Maine Molecular Quality Controls), Amplicheck Series (BD Company), and AcroMetrix Series (Thermo Fisher Scientific) are a few examples of the multi-analyte controls that are offered on the market. With the aid of these controls, laboratories can do quality control for a variety of parameters, such as cardiac and tumor indicators, DNA/RNA of various infectious disease-causing agents, and multiple parameters simultaneously.
CHALLENGES
Strict regulatory requirements for IVD products
New multi-analyte and mu probes have been created as a result of technological advances. In the US and Europe, there are stricter legal and regulatory standards for IVD, including molecular diagnostics. IVD products are defined by 21 CFR 809 in the US, and they are subject to the same regulations as apply to medical devices. New FDA guidance documents were published by the FDA. Device manufacturers are required by US federal regulations to submit a 510(k) application for any further modifications to a device.
The molecular quality control market may be affected in a number of ways by the current conflict between Russia and Ukraine. The international community's sanctions on Russia as a result of its conduct in Ukraine may result in a decline in the import and export of products and services, which may cause a disruption in the supply chain for molecular quality controls. The volatility in the area may also have an influence on company and investment confidence, which may have an effect on market expansion.
IMPACT OF ONGOING RECESSION
The recession is expected to have little of a negative effect on the market for molecular quality controls. Hospital CAPEX restrictions are anticipated to lead to a slowdown in the diagnostic imaging industry, which may prevent hospitals from making purchases of equipment. As the primary market for molecular quality controls is the medical industry, these will reduce demand for them. Given that end-use sectors are under pressure from growing raw material costs, demand-side factors may have the biggest impact on this market.
By Product
Independent Controls
Instrument-Specific Controls
In 2022, independent controls segment is expected to dominate the global molecular quality controls due to its advantages, including their use across various reagent lots, third-party independent quality controls are being used more frequently, which helps lower operating costs and accounts for the big proportion of this market.
By Analyte Type
Single-Analyte Controls
Multi-Analyte Controls
In 2022, single-analyte controls segment is expected to dominate the global molecular quality controls market due to the widespread use of singleplex assays in hospitals and the low danger of cross-reactivity, this category has a substantial market share.
By Application
Infectious Diseases
Oncology
Genetic Testing
Other Applications
By End User
Clinical Laboratories
Hospitals
IVD Manufacturers and Contract Research Organizations
Academic and Research Institutes
Other End Users
.png)
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
North America held a significant market share in 2022 and is likely to maintain its dominance during the projection owing to developed healthcare system in Canada and US and also the presence of many key manufacturer of molecular quality controls product.
Asia-Pacific is witness to increase at the highest rate during the forecast period. The market in the region is being driven by the increasing healthcare needs, rising focus on improving the quality of laboratory testing and strategic developments of leading key players. Also, the rapid growth in the number of accredited laboratories also helps to drive the market share of molecular quality controls product.
The major key players are SeraCare Life Sciences, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Microbiologics, Inc., ZeptoMetrix Corporation, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Quidel Corporation, Qnostics, Maine Molecular Quality Controls, INC., Danaher., Helena Biosciences Europe, SERO AS, Technopath Clinical Diagnostics, and Randox Laboratories Ltd., and others.
Thermo Fisher Scientific, in 2023, The Binding Site Group was purchased by Thermo Fisher Scientific (US) in order to add cutting-edge innovation in multiple myeloma diagnostics and monitoring to the company's current speciality diagnostics portfolio.
Microbiologics Inc., in 2022, Cryologics was purchased by Microbiologics Inc. in order to increase the company's ability to provide quality control microbiologists who are committed to the security of pharmaceutical and personal care products with more resources.
| Report Attributes | Details |
| Market Size in 2022 | US$ 0.17 Billion |
| Market Size by 2030 | US$ 0.28 Billion |
| CAGR | CAGR of 6.8% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Independent Controls, Instrument-Specific Controls) • By Analyte Type (Single-Analyte Controls, Multi-Analyte Controls) • By Application (Infectious Diseases, Oncology, Genetic Testing, Other Applications) • By End User (Clinical Laboratories, Hospitals, IVD Manufacturers and Contract Research Organizations, Academic and Research Institutes, Other End Users) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | SeraCare Life Sciences, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Microbiologics, Inc., ZeptoMetrix Corporation, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Quidel Corporation, Qnostics, Maine Molecular Quality Controls, INC., Danaher., Helena Biosciences Europe, SERO AS, Technopath Clinical Diagnostics, and Randox Laboratories Ltd. |
| Key Drivers | • Increasing preference for personalized medicines • Adoption of Third-Party Quality Controls • the provision of funding to researchers for the creation of innovative interventions |
| Market Opportunity | • Rising demand for multi- analyst control |
Ans: The Molecular Quality Controls Market is expected to grow at 6.8% CAGR from 2023 to 2030.
Ans: According to our analysis, the Molecular Quality Controls Market is anticipated to reach USD 0.28 billion By 2030.
Ans: The leading participants are SeraCare Life Sciences, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Microbiologics, Inc., ZeptoMetrix Corporation, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Quidel Corporation, Qnostics, Maine Molecular Quality Controls, INC., Danaher., Helena Biosciences Europe, SERO AS, Technopath Clinical Diagnostics, and Randox Laboratories Ltd., and others
Ans: Factors such as increasing preference for personalized medicines and adoption of Third-Party Quality Controls.
Ans: Yes, you may request customization based on your company's needs.
TABLE OF CONTENT
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Molecular Quality Controls Market Segmentation, by Product
8.1 Independent Controls
8.2 Instrument-Specific Controls
9. Molecular Quality Controls Market Segmentation, by Analyte Type
9.1 Single-Analyte Controls
9.2 Multi-Analyte Controls
10. Molecular Quality Controls Market Segmentation, by Application
10.1 Infectious Diseases
10.2 Oncology
10.3 Genetic Testing
10.4 Other Applications
11. Molecular Quality Controls Market Segmentation, by End User
11.1 Clinical Laboratories
11.2 Hospitals
11.3 IVD Manufacturers and Contract Research Organizations
11.4 Academic and Research Institutes
11.5 Other End Users
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Molecular Quality Controls Market by Country
12.2.2 North America Molecular Quality Controls Market by Product
12.2.3 North America Molecular Quality Controls Market by Analyte Type
12.2.4 North America Molecular Quality Controls Market by Application
12.2.5 North America Molecular Quality Controls Market by End User
12.2.6 USA
12.2.6.1 USA Molecular Quality Controls Market by Type
12.2.6.2 USA Molecular Quality Controls Market by Analyte Type
12.2.6.3 USA Molecular Quality Controls Market by Application
12.2.6.4 USA Molecular Quality Controls Market by End User
12.2.7 Canada
12.2.7.1 Canada Molecular Quality Controls Market by Type
12.2.7.2 Canada Molecular Quality Controls Market by Analyte Type
12.2.7.3 Canada Molecular Quality Controls Market by Application
12.2.7.4 Canada Molecular Quality Controls Market by End User
12.2.8 Mexico
12.2.8.1 Mexico Molecular Quality Controls Market by Type
12.2.8.2 Mexico Molecular Quality Controls Market by Analyte Type
12.2.8.3 Mexico Molecular Quality Controls Market by Application
12.2.8.4 Mexico Molecular Quality Controls Market by End User
12.3 Europe
12.3.1 Eastern Europe
12.3.1.1 Eastern Europe Molecular Quality Controls Market by Country
12.3.1.2 Eastern Europe Molecular Quality Controls Market by Type
12.3.1.3 Eastern Europe Molecular Quality Controls Market by Analyte Type
12.3.1.4 Eastern Europe Molecular Quality Controls Market by Application
12.3.1.5 Eastern Europe Molecular Quality Controls Market by End User
12.3.1.6 Poland
12.3.1.6.1 Poland Molecular Quality Controls Market by Type
12.3.1.6.2 Poland Molecular Quality Controls Market by Analyte Type
12.3.1.6.3 Poland Molecular Quality Controls Market by Application
12.3.1.6.4 Poland Molecular Quality Controls Market by End User
12.3.1.7 Romania
12.3.1.7.1 Romania Molecular Quality Controls Market by Type
12.3.1.7.2 Romania Molecular Quality Controls Market by Analyte Type
12.3.1.7.3 Romania Molecular Quality Controls Market by Application
12.3.1.7.4 Romania Molecular Quality Controls Market by End User
12.3.1.8 Hungary
12.3.1.8.1 Hungary Molecular Quality Controls Market by Product Type
12.3.1.8.2 Hungary Molecular Quality Controls Market by Analyte Type
12.3.1.8.3 Hungary Molecular Quality Controls Market by Application
12.3.1.8.4 Hungary Molecular Quality Controls Market by End User
12.3.1.9 Turkey
12.3.1.9.1 Turkey Molecular Quality Controls Market by Product Type
12.3.1.9.2 Turkey Molecular Quality Controls Market by Analyte Type
12.3.1.9.3 Turkey Molecular Quality Controls Market by Application
12.3.1.9.4 Turkey Molecular Quality Controls Market by End User
12.3.1.10 Rest of Eastern Europe
12.3.1.10.1 Rest of Eastern Europe Molecular Quality Controls Market by Product Type
12.3.1.10.2 Rest of Eastern Europe Molecular Quality Controls Market by Analyte Type
12.3.1.10.3 Rest of Eastern Europe Molecular Quality Controls Market by Application
12.3.1.10.4 Rest of Eastern Europe Molecular Quality Controls Market by End User
12.3.2 Western Europe
12.3.2.1 Western Europe Molecular Quality Controls Market by Country
12.3.2.2 Western Europe Molecular Quality Controls Market by Product Type
12.3.2.3 Western Europe Molecular Quality Controls Market by Analyte Type
12.3.2.4 Western Europe Molecular Quality Controls Market by Application
12.3.2.5 Western Europe Molecular Quality Controls Market by End User
12.3.2.6 Germany
12.3.2.6.1 Germany Molecular Quality Controls Market by Product Type
12.3.2.6.2 Germany Molecular Quality Controls Market by Analyte Type
12.3.2.6.3 Germany Molecular Quality Controls Market by Application
12.3.2.6.4 Germany Molecular Quality Controls Market by End User
12.3.2.7 France
12.3.2.7.1 France Molecular Quality Controls Market by Product Type
12.3.2.7.2 France Molecular Quality Controls Market by Analyte Type
12.3.2.7.3 France Molecular Quality Controls Market by Application
12.3.2.7.4 France Molecular Quality Controls Market by End User
12.3.2.8 UK
12.3.2.8.1 UK Molecular Quality Controls Market by Product Type
12.3.2.8.2 UK Molecular Quality Controls Market by Analyte Type
12.3.2.8.3 UK Molecular Quality Controls Market by Application
12.3.2.8.4 UK Molecular Quality Controls Market by End User
12.3.2.9 Italy
12.3.2.9.1 Italy Molecular Quality Controls Market by Product Type
12.3.2.9.2 Italy Molecular Quality Controls Market by Analyte Type
12.3.2.9.3 Italy Molecular Quality Controls Market by Application
12.3.2.9.4 Italy Molecular Quality Controls Market by End User
12.3.2.10 Spain
12.3.2.10.1 Spain Molecular Quality Controls Market by Product Type
12.3.2.10.2 Spain Molecular Quality Controls Market by Analyte Type
12.3.2.10.3 Spain Molecular Quality Controls Market by Application
12.3.2.10.4 Spain Molecular Quality Controls Market by End User
12.3.2.11 Netherlands
12.3.2.11.1 Netherlands Molecular Quality Controls Market by Product Type
12.3.2.11.2 Netherlands Molecular Quality Controls Market by Analyte Type
12.3.2.11.3 Netherlands Molecular Quality Controls Market by Application
12.3.2.11.4 Netherlands Molecular Quality Controls Market by End User
12.3.2.12 Switzerland
12.3.2.12.1 Switzerland Molecular Quality Controls Market by Product Type
12.3.2.12.2 Switzerland Molecular Quality Controls Market by Analyte Type
12.3.2.12.3 Switzerland Molecular Quality Controls Market by Application
12.3.2.12.4 Switzerland Molecular Quality Controls Market by End User
12.3.2.13 Austria
12.3.2.13.1 Austria Molecular Quality Controls Market by Product Type
12.3.2.13.2 Austria Molecular Quality Controls Market by Analyte Type
12.3.2.13.3 Austria Molecular Quality Controls Market by Application
12.3.2.13.4 Austria Molecular Quality Controls Market by End User
12.3.2.14 Rest of Western Europe
12.3.2.14.1 Rest of Western Europe Molecular Quality Controls Market by Product Type
12.3.2.14.2 Rest of Western Europe Molecular Quality Controls Market by Analyte Type
12.3.2.14.3 Rest of Western Europe Molecular Quality Controls Market by Application
12.3.2.14.4 Rest of Western Europe Molecular Quality Controls Market by End User
12.4 Asia-Pacific
12.4.1 Asia Pacific Molecular Quality Controls Market by Country
12.4.2 Asia Pacific Molecular Quality Controls Market by Product Type
12.4.3 Asia Pacific Molecular Quality Controls Market by Analyte Type
12.4.4 Asia Pacific Molecular Quality Controls Market by Application
12.4.5 Asia Pacific Molecular Quality Controls Market by End User
12.4.6 China
12.4.6.1 China Molecular Quality Controls Market by Product Type
12.4.6.2 China Molecular Quality Controls Market by Analyte Type
12.4.6.3 China Molecular Quality Controls Market by Application
12.4.6.4 China Molecular Quality Controls Market by End User
12.4.7 India
12.4.7.1 India Molecular Quality Controls Market by Product Type
12.4.7.2 India Molecular Quality Controls Market by Analyte Type
12.4.7.3 India Molecular Quality Controls Market by Application
12.4.7.4 India Molecular Quality Controls Market by End User
12.4.8 Japan
12.4.8.1 Japan Molecular Quality Controls Market by Product Type
12.4.8.2 Japan Molecular Quality Controls Market by Analyte Type
12.4.8.3 Japan Molecular Quality Controls Market by Application
12.4.8.4 Japan Molecular Quality Controls Market by End User
12.4.9 South Korea
12.4.9.1 South Korea Molecular Quality Controls Market by Product Type
12.4.9.2 South Korea Molecular Quality Controls Market by Analyte Type
12.4.9.3 South Korea Molecular Quality Controls Market by Application
12.4.9.4 South Korea Molecular Quality Controls Market by End User
12.4.10 Vietnam
12.4.10.1 Vietnam Molecular Quality Controls Market by Product Type
12.4.10.2 Vietnam Molecular Quality Controls Market by Analyte Type
12.4.10.3 Vietnam Molecular Quality Controls Market by Application
12.4.10.4 Vietnam Molecular Quality Controls Market by End User
12.4.11 Singapore
12.4.11.1 Singapore Molecular Quality Controls Market by Product Type
12.4.11.2 Singapore Molecular Quality Controls Market by Analyte Type
12.4.11.3 Singapore Molecular Quality Controls Market by Application
12.4.11.4 Singapore Molecular Quality Controls Market by End User
12.4.12 Australia
12.4.12.1 Australia Molecular Quality Controls Market by Product Type
12.4.12.2 Australia Molecular Quality Controls Market by Analyte Type
12.4.12.3 Australia Molecular Quality Controls Market by Application
12.4.12.4 Australia Molecular Quality Controls Market by End User
12.4.13 Rest of Asia-Pacific
12.4.13.1 Rest of Asia-Pacific Molecular Quality Controls Market by Product Type
12.4.13.2 Rest of Asia-Pacific Molecular Quality Controls Market by Analyte Type
12.4.13.3 Rest of Asia-Pacific Molecular Quality Controls Market by Application
12.4.13.4 Rest of Asia-Pacific Molecular Quality Controls Market by End User
12.5 Middle East & Africa
12.5.1 Middle East
12.5.1.1 Middle East Molecular Quality Controls Market by country
12.5.1.2 Middle East Molecular Quality Controls Market by Product Type
12.5.1.3 Middle East Molecular Quality Controls Market by Analyte Type
12.5.1.4 Middle East Molecular Quality Controls Market by Application
12.5.1.5 Middle East Molecular Quality Controls Market by End User
12.5.1.6 UAE
12.5.1.6.1 UAE Molecular Quality Controls Market by Product Type
12.5.1.6.2 UAE Molecular Quality Controls Market by Analyte Type
12.5.1.6.3 UAE Molecular Quality Controls Market by Application
12.5.1.6.4 UAE Molecular Quality Controls Market by End User
12.5.1.7 Egypt
12.5.1.7.1 Egypt Molecular Quality Controls Market by Product Type
12.5.1.7.2 Egypt Molecular Quality Controls Market by Analyte Type
12.5.1.7.3 Egypt Molecular Quality Controls Market by Application
12.5.1.7.4 Egypt Molecular Quality Controls Market by End User
12.5.1.8 Saudi Arabia
12.5.1.8.1 Saudi Arabia Molecular Quality Controls Market by Product Type
12.5.1.8.2 Saudi Arabia Molecular Quality Controls Market by Analyte Type
12.5.1.8.3 Saudi Arabia Molecular Quality Controls Market by Application
12.5.1.8.4 Saudi Arabia Molecular Quality Controls Market by End User
12.5.1.9 Qatar
12.5.1.9.1 Qatar Molecular Quality Controls Market by Product Type
12.5.1.9.2 Qatar Molecular Quality Controls Market by Analyte Type
12.5.1.9.3 Qatar Molecular Quality Controls Market by Application
12.5.1.9.4 Qatar Molecular Quality Controls Market by End User
12.5.1.10 Rest of Middle East
12.5.1.10.1 Rest of Middle East Molecular Quality Controls Market by Product Type
12.5.1.10.2 Rest of Middle East Molecular Quality Controls Market by Analyte Type
12.5.1.10.3 Rest of Middle East Molecular Quality Controls Market by Application
12.5.1.10.4 Rest of Middle East Molecular Quality Controls Market by End User
12.5.2. Africa
12.5.2.1 Africa Molecular Quality Controls Market by country
12.5.2.2 Africa Molecular Quality Controls Market by Product Type
12.5.2.3 Africa Molecular Quality Controls Market by Analyte Type
12.5.2.4 Africa Molecular Quality Controls Market by Application
12.5.2.5 Africa Molecular Quality Controls Market by End User
12.5.2.6 Nigeria
12.5.2.6.1 Nigeria Molecular Quality Controls Market by Product Type
12.5.2.6.2 Nigeria Molecular Quality Controls Market by Analyte Type
12.5.2.6.3 Nigeria Molecular Quality Controls Market by Application
12.5.2.6.4 Nigeria Molecular Quality Controls Market by End User
12.5.2.7 South Africa
12.5.2.7.1 South Africa Molecular Quality Controls Market by Product Type
12.5.2.7.2 South Africa Molecular Quality Controls Market by Analyte Type
12.5.2.7.3 South Africa Molecular Quality Controls Market by Application
12.5.2.7.4 South Africa Molecular Quality Controls Market by End User
12.5.2.8 Rest of Africa
12.5.2.8.1 Rest of Africa Molecular Quality Controls Market by Product Type
12.5.2.8.2 Rest of Africa Molecular Quality Controls Market by Analyte Type
12.5.2.8.3 Rest of Africa Molecular Quality Controls Market by Application
12.5.2.8.4 Rest of Africa Molecular Quality Controls Market by End User
12.6. Latin America
12.6.1 Latin America Molecular Quality Controls Market by country
12.6.2 Latin America Molecular Quality Controls Market by Product Type
12.6.3 Latin America Molecular Quality Controls Market by Analyte Type
12.6.4 Latin America Molecular Quality Controls Market by Application
12.6.5 Latin America Molecular Quality Controls Market by End User
12.6.6 Brazil
12.6.6.1 Brazil Molecular Quality Controls Market by Product Type
12.6.6.2 Brazil Molecular Quality Controls Market by Analyte Type
12.6.6.3 Brazil Molecular Quality Controls Market by Application
12.6.6.4 Brazil Molecular Quality Controls Market by End User
12.6.7 Argentina
12.6.7.1 Argentina Molecular Quality Controls Market by Product Type
12.6.7.2 Argentina Molecular Quality Controls Market by Analyte Type
12.6.7.3 Argentina Molecular Quality Controls Market by Application
12.6.7.4 Argentina Molecular Quality Controls Market by End User
12.6.8 Colombia
12.6.8.1 Colombia Molecular Quality Controls Market by Product Type
12.6.8.2 Colombia Molecular Quality Controls Market by Analyte Type
12.6.8.3 Colombia Molecular Quality Controls Market by Application
12.6.8.4 Colombia Molecular Quality Controls Market by End User
12.6.9 Rest of Latin America
12.6.9.1 Rest of Latin America Molecular Quality Controls Market by Product Type
12.6.9.2 Rest of Latin America Molecular Quality Controls Market by Analyte Type
12.6.9.3 Rest of Latin America Molecular Quality Controls Market by Application
12.6.9.4 Rest of Latin America Molecular Quality Controls Market by End User
13 Company Profile
13.1 SeraCare Life Sciences, Inc.
13.1.1 Company Overview
13.1.2 Financials
13.1.3 Products/ Services Offered
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Thermo Fisher Scientific Inc.
13.2.1 Company Overview
13.2.2 Financials
13.2.3 Products/ Services Offered
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Bio Rad Laboratories, Inc.
13.3.1 Company Overview
13.3.2 Financials
13.3.3 Products/ Services Offered
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 Microbiologics, Inc.
13.4.1 Company Overview
13.4.2 Financials
13.4.3 Products/ Services Offered
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 ZeptoMetrix Corporation
13.5.1 Company Overview
13.5.2 Financials
13.5.3 Products/ Services Offered
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 F. Hoffmann-La Roche Ltd
13.6.1 Company Overview
13.6.2 Financials
13.6.3 Products/ Services Offered
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Abbott Laboratories
13.7.1 Company Overview
13.7.2 Financials
13.7.3 Products/ Services Offered
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Quidel Corporation
13.8.1 Company Overview
13.8.2 Financials
13.8.3 Products/ Services Offered
13.8.4 SWOT Analysis
13.8.5 The SNS View
13.9 Qnostics
13.9.1 Company Overview
13.9.2 Financials
13.9.3 Products/ Services Offered
13.9.4 SWOT Analysis
13.9.5 The SNS View
13.10 Maine Molecular Quality Controls INC.
13.10.1 Company Overview
13.10.2 Financials
13.10.3 Products/ Services Offered
13.10.4 SWOT Analysis
13.10.5 The SNS View
13.11 Danaher.
13.11.1 Company Overview
13.11.2 Financials
13.11.3 Products/ Services Offered
13.11.4 SWOT Analysis
13.11.5 The SNS View
13.12 Helena Biosciences Europe
13.12.1 Company Overview
13. 12.2 Financials
13. 12.3 Products/ Services Offered
13. 12.4 SWOT Analysis
13. 12.5 The SNS View
13.13 SERO AS
13. 13.1 Company Overview
13. 13.2 Financials
13. 13.3 Products/ Services Offered
13. 13.4 SWOT Analysis
13. 13.5 The SNS View
13.14 Technopath Clinical Diagnostics
13. 14.1 Company Overview
13. 14.2 Financials
13. 14.3 Products/ Services Offered
13. 14.4 SWOT Analysis
13. 14.5 The SNS View
13.15 Randox Laboratories Ltd.
13. 15.1 Company Overview
13. 15.2 Financials
13. 15.3 Products/ Services Offered
13. 15.4 SWOT Analysis
13. 15.5 The SNS View
14. Competitive Landscape
14.1 Competitive Bench marking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. USE Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Botulinum Toxin Market size was valued at USD 7.26 billion in 2023 and it is expected to be worth around USD 17.73 billion by 2031 growing at a remarkable GAGR of 11.8% over the forecast period 2024-2031.
The DNA Synthesizer Market size was estimated USD 229.2 million in 2022 and is expected to reach USD 677.1 million by 2030 at a CAGR of 14.5% during the forecast period of 2023-2030.
The ECG Equipment and Management System market is anticipated to arrive at USD 9.77 billion by 2030. From 2023 to 2030, the market is assessed to develop at a CAGR of 6.38%.
The AI in Cancer Diagnosis market was valued at USD 118.54 billion in 2022 and is expected to reach at USD 845.78 billion by 2030 and grow at a CAGR of 27.8% over the forecast period of 2023-2030.
The Magnetic Resonance Imaging (MRI) Market was valued at USD 5.4 Bn in 2022 and is expected to reach USD 8.93 Bn by 2030 and grow at a CAGR of 6.5% during the forecasted period 2023-2030.
The Blood Grouping Reagents Market Size was valued at USD 1972.26 million in 2023, and is expected to reach USD 3570.19 million by 2031 and grow at a CAGR of 7.7% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
